Respiratory Disease in the COVID-19 Era

• Outros Autores: Okamoto, Masaki (Editor)
• Formato: Recurso Electrónico Capítulo de Livro
• Idioma: inglês
• Publicado em: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Assuntos: Medicine; Epidemiology & medical statistics; heart rate; COVID-19; pulmonary rehabilitation; COVID-19 vaccines; adult; pneumonia; risk; SARS-CoV-2; Pneumocystis jirovecii pneumonia; interstitial pneumonia; steroids; immunosuppressive drugs; spontaneous pneumomediastinum; subcutaneous emphysema; therapeutic plasma exchange; ARDS; inflammatory markers; survival; immunocompromised host; Bruton's tyrosine kinase; persistent infection; pulmonary paragonimiasis; Paragonimus westermani; post-COVID-19 condition; delayed diagnosis; case cluster; Bamlanivimab; Etesevimab; lung ultrasound; RT-qPCR; HRCT; diabetes mellitus; computed tomographic severity score; immunocompromised; coronavirus disease 2019; hydroxychloroquine; severe acute respiratory syndrome; n/a; diaphragm; thoracic mobilization; respiratory function
• Acesso em linha: DOAB: download the publication; DOAB: description of the publication

Coronavirus disease 2019 (COVID-19) is a new respiratory disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused a global pandemic. COVID-19 patients often develop acute respiratory distress syndrome (ARDS), which involves acute and lethal respirator...